DocMorris AG (DOCM.SW)
Swiss · CHF · Healthcare · Pharmaceutical Retailers
CHF 14.87 (-3.13%) as of
Key statistics
- Market cap
- 758.09M
- Forward P/E
- -16.87
- EPS (TTM)
- -2.54
- Dividend yield
- 0.00%
- 52-week range
- 3.92 – 16.58
- Beta
- 1.78
- Revenue (TTM)
- 1.18B
- Profit margin
- -10.65%
- Analyst target
- CHF 12.41
- Volume
- 545.82k
About DocMorris AG
DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. The company offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insurers, and health institutions. It sells its products to online mail-order pharmacies, and private individuals under the DocMorris, PromoFarma by DocMorris, and TeleClinic brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Headquarters
- Frauenfeld, Switzerland
- Employees
- 1,097
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.